Development Level

Tchem 2 | 1,890
Tbio 1 | 10,625
Tclin 1 | 602

IMPC Term

abnormal behavior 1 | 226
abnormal femur morphology 1 | 14
decreased blood urea nitrogen ... 1 | 31
decreased circulating triglyce... 1 | 83
decreased mean corpuscular vol... 1 | 50
embryonic lethality prior to t... 1 | 187
increased fasted circulating g... 1 | 68
preweaning lethality, complete... 1 | 633

Disease

osteosarcoma 4 | 7,933
Cancer 3 | 2,346
glioblastoma 3 | 5,572
ovarian cancer 3 | 8,492
Neoplasm Invasiveness 2 | 127
Vascular disease 2 | 281
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
Agammaglobulinemia 1 | 24
Alzheimer's disease 1 | 644
Arthritis 1 | 248
Atelosteogenesis 1 | 4
Autosomal Recessive Polycystic Kidney Disease 1 | 5
Bladder Neoplasm 1 | 109
Blastic phase chronic myeloid leukemia 1 | 58
Boomerang dysplasia 1 | 3
Breast cancer 1 | 3,099
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B (disorder) 1 | 1
COPD 1 | 116
Carcinoma 1 | 2,147
Carcinoma of colon 1 | 32
Cardiomegaly 1 | 66
Cardiomyopathy 1 | 110
Cardiovascular system disease 1 | 194
Central sleep apnea 1 | 12
Centronuclear myopathy 1 | 21
Charcot-Marie-Tooth disease 1 | 74
Charcot-Marie-Tooth disease 2M 1 | 1
Charcot-Marie-Tooth disease, dominant, intermediate type, B 1 | 1
Cherubism 1 | 14
Chronic Myelocytic Leukemia Accelerated Phase 1 | 59
Chronic phase chronic myeloid leukemia 1 | 45
Colitis 1 | 46
Colonic Neoplasms 1 | 126
Congenital Structural Myopathy 1 | 4
DNM2-related intermediate Charcot-Marie-Tooth neuropathy 1 | 1
Gastrointestinal system disease 1 | 50
Hereditary spherocytosis 1 | 20
Kidney disease 1 | 397
Larsen syndrome 1 | 11
Lethal congenital contracture syndrome 5 1 | 1
Liver carcinoma 1 | 217
Mammary Neoplasms 1 | 410
Melanoma 1 | 261
Multiple myeloma 1 | 1,328
Myopathy 1 | 128
Myopathy, Centronuclear, Autosomal Dominant 1 | 3
Myopathy, centronuclear, 1 1 | 3
Neurodegenerative disease 1 | 383
Neuropathy 1 | 210
Noonan Syndrome 1 | 33
Osteopetrosis 1 | 40
Osteoporosis 1 | 259
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 1 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 1 | 47
Pick disease 1 | 1,893
Ptosis 1 | 42
Rheumatoid Arthritis 1 | 1,171
Squamous cell carcinoma 1 | 96
Status Epilepticus 1 | 85
Urinary bladder cancer 1 | 34
X-linked centronuclear myopathy 1 | 3
atypical teratoid / rhabdoid tumor 1 | 4,369
dermatomyositis 1 | 967
diabetes mellitus 1 | 1,663
group 4 medulloblastoma 1 | 1,875
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
medulloblastoma, large-cell 1 | 6,234
mucosa-associated lymphoid tissue lymphoma 1 | 480
non-small cell lung cancer 1 | 2,798
oligodendroglioma 1 | 2,849
psoriasis 1 | 6,685
spina bifida 1 | 1,064
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 1,563

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Kinase 2 | 634
Enzyme 1 | 4,146
Non-IDG 1 | 11,969

Grant Application

5R29CA077697-05 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Dynamin-2 DNM2 Tchem Non-IDG -3.23628 1426.1 125
Proto-oncogene tyrosine-protein kinase Src SRC Tclin Kinase -3.98540 8801.0 1257
Focal adhesion kinase 1 PTK2 Tchem Kinase -3.03447 956.9 1799
Serine/threonine-protein phosphatase 6 catalytic subunit PPP6C Tbio Enzyme -2.39214 71.1 190